atorvastatin has been researched along with Local Neoplasm Recurrence in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borre, M; Boström, P; Ettala, O; Fode, M; Helminen, M; Koskimäki, J; Kotsar, A; Lehtimäki, T; Löffeler, S; Marttila, T; Murtola, TJ; Pakarainen, T; Raittinen, PV; Rannikko, A; Riikonen, J; Ronkainen, H; Salonen, A; Seikkula, H; Siltari, A; Tammela, T; Østergren, P | 1 |
| Li, Q; Liu, S; Tang, X; Xu, W; Yang, F | 1 |
| Hong, JH; Jeong, IG; Kim, CS; Lim, B; Lim, JH; Yun, SC | 1 |
| Gao, J; Gao, Y; He, X; He, Y; Li, K; Liu, S; Ma, Q; Pan, W; Qi, Y; Song, W; Wei, L; Xu, J; Xu, P; Xu, X; Yang, Y; Yin, W; Yuan, X; Zhang, J | 1 |
2 trial(s) available for atorvastatin and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol.
Topics: Androgen Antagonists; Androgens; Atorvastatin; Cholesterol; Clinical Trials, Phase III as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Quality of Life; Randomized Controlled Trials as Topic | 2022 |
Adjuvant Low-dose Statin Use after Radical Prostatectomy: The PRO-STAT Randomized Clinical Trial.
Topics: Aged; Atorvastatin; Chemotherapy, Adjuvant; Double-Blind Method; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Prostatectomy; Prostatic Neoplasms | 2021 |
2 other study(ies) available for atorvastatin and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Efficacy of atorvastatin administration after surgery in patients with chronic subdural hematoma.
Topics: Activities of Daily Living; Atorvastatin; Hematoma; Hematoma, Subdural, Chronic; Humans; Neoplasm Recurrence, Local; Recurrence; Retrospective Studies; Treatment Outcome | 2023 |
Atorvastatin Inhibits Breast Cancer Cells by Downregulating PTEN/AKT Pathway via Promoting Ras Homolog Family Member B (RhoB).
Topics: Animals; Apoptosis; Atorvastatin; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Recurrence, Local; Prognosis; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; rhoB GTP-Binding Protein; Signal Transduction; Up-Regulation; Xenograft Model Antitumor Assays | 2019 |